GGrantIndex
← Leaderboards

Nira Ben-Jonathan

University Of Cincinnati

$6,714,377
Attributed
$6,714,377
Total exposure
9
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $649.6K · FY200515
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15

Funding mix

By agency

NIH$6,714,377 · 9

By mechanism

R01$4,749,750 · 3
U01$931,259 · 1
R21$848,868 · 2
R55$100,000 · 1
R03$76,500 · 1
R13$8,000 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Cincinnati

Same institution · by research overlap

Others in their field

Top investigators on “Prolactin

Research focus

ProlactinEstrogen ReceptorsSerumHormonesPituitary GlandGene ExpressionDoseCell LineSubcutaneousAdipocytesFemaleAdipose TissueAffectCytokineProductionCellsEstrogensBreastRodentTissuesObesityPlayExposure ToEnzymes

Grant awards (31)

Bisphenol A and the Metabolic Syndrome: Focus on Adipose Tissue Functions$95,100
U01 · FY2015 · ES · contact PI
Bisphenol A and the Metabolic Syndrome: Focus on Adipose Tissue Functions$173,852
U01 · FY2014 · ES · contact PI
Bisphenol A and the Metabolic Syndrome: Focus on Adipose Tissue Functions$273,730
U01 · FY2013 · ES · contact PI
Prolactin as a Growth Factor in Breast Cancer$229,283
R01 · FY2013 · CA · contact PI
Bisphenol A and the Metabolic Syndrome: Focus on Adipose Tissue Functions$282,600
U01 · FY2012 · ES · contact PI
Prolactin as a Growth Factor in Breast Cancer$243,918
R01 · FY2012 · CA · contact PI
Prolactin as a Growth Factor in Breast Cancer$243,918
R01 · FY2011 · CA · contact PI
Bisphenol A and the Metabolic Syndrome: Focus on Adipose Tissue Functions$105,977
U01 · FY2011 · ES · contact PI
Satellite Symposium on Obesity and Endocrine Disruptors$8,000
R13 · FY2011 · ES · contact PI
Prolactin as a Growth Factor in Breast Cancer$251,462
R01 · FY2010 · CA · contact PI
Prolactin as a Growth Factor in Breast Cancer$251,462
R01 · FY2009 · CA · contact PI
Exposure to Bisphenol A: Inhibition of Adiponectin Release by Human Adipocytes$234,000
R21 · FY2009 · ES · contact PI
Exposure to Bisphenol A: Inhibition of Adiponectin Release by Human Adipocytes$113,868
R21 · FY2009 · ES · contact PI
Prolactin as a Growth Factor in Breast Cancer$238,696
R01 · FY2008 · CA · contact PI
Exposure to Bisphenol A: Inhibition of Adiponectin Release by Human Adipocytes$195,000
R21 · FY2008 · ES · contact PI
Prolactin as a Growth Factor in Breast Cancer$238,696
R01 · FY2007 · CA · contact PI
Prolactin as a Growth Factor in Breast Cancer$367,138
R01 · FY2006 · CA · contact PI
Xenoestrogens: Genomic and Non-genomic Mechanisms$280,238
R01 · FY2006 · ES · contact PI
Prolactin as a Growth Factor in Breast Cancer$362,305
R01 · FY2005 · CA
Xenoestrogens: Genomic and Non-genomic Mechanisms$287,250
R01 · FY2005 · ES
Xenoestrogens: Genomic and Non-genomic Mechanisms$287,378
R01 · FY2004 · ES
Prolactin as a Growth Factor in Breast Cancer$251,740
R01 · FY2004 · CA
Xenoestrogens: Genomic and Non-genomic Mechanisms$287,503
R01 · FY2003 · ES
NEONATAL EFFECTS AND METABOLISM OF XENOESTROGENS$236,039
R01 · FY2003 · ES
NEONATAL EFFECTS AND METABOLISM OF XENOESTROGENS$229,169
R01 · FY2002 · ES
Prolactin and Estrogens as Mitogens in Prostate Cancer$153,000
R21 · FY2002 · DK
NEONATAL EFFECTS AND METABOLISM OF XENOESTROGENS$222,494
R01 · FY2001 · ES
Prolactin and Estrogens as Mitogens in Prostate Cancer$153,000
R21 · FY2001 · DK
NEONATAL EFFECTS AND METABOLISM OF XENOESTROGENS$241,061
R01 · FY2000 · ES
ANGIOSTATIC FUNCTION OF HUMAN 16K PROLACTIN$100,000
R55 · FY2000 · CA
XENOESTROGENS AND THE DEVELOPING NEUROENDOCRINE AXIS$76,500
R03 · FY2000 · ES